Natera is collaborating with Imperial College London and the University of Leicester to evaluate use of the company’s Signatera research-use-only personalized ctDNA technology for detecting disease recurrence among women breast cancer patients.
Read More
Sysmex Inostics has announced new data from a real-world prospective evaluation of the OncoBeam RAS CRC test, a liquid biopsy assay for use in metastatic colorectal cancer patients.
Read More
The Centers for Medicare and Medicaid Services has granted OncoCyte CLIA certification for its clinical lab facility in Alameda, Calif.
Read More
The study will recruit up to 3,000 patients across 21 sites in the UK and Europe.
Read MoreDavid A. Ahlquist, MD, coinventor of the Cologuard stool-based DNA screening test for colorectal cancer, discusses updated USPSTF guidelines that seek to increase screening rates.
Read More